FIRST LOAN MODIFICATION AGREEMENTFirst Loan Modification Agreement • August 16th, 2016 • Xtant Medical Holdings, Inc. • Biological products, (no disgnostic substances)
This First Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of August 12, 2016, by and among (a) SILICON VALLEY BANK, a California corporation (“Bank”), and (b) (i) XTANT MEDICAL HOLDINGS, INC., a Delaware corporation (“Holdings”), (ii) BACTERIN INTERNATIONAL, INC., a Nevada corporation (“Bacterin”), (iii) X-SPINE SYSTEMS, INC., an Ohio corporation (“X-spine”), and (iv) XTANT MEDICAL, INC., a Delaware corporation (“Xtant”, and together with Holdings, Bacterin and X-spine, individually and collectively, jointly and severally, the “Borrower”).
